A Single-Institution Audit of Chemo-PORT Placements During Breast Surgery with Literature Review for Management of Common Complications

Abstract Most breast cancer patients need chemotherapy for a duration of 3–12 months. The morbidity of frequent intravenous access, mainly on the contralateral upper limb is troublesome and chemo-PORT placement is helpful. We analysed a prospective database of patients who had concurrent chemo-PORT placement with breast surgery between January-2019 and December-2023 at our centre for their complication rate. Clinico-pathological data was collected from electronic medical records and analysed in SPSS-V25. A total of 408 breast cancer patients underwent chemo-PORT placement. The median age of cohort was 50 years(18–78). Breast conservation surgery was done in 201(49.3%), 207(51.7%) had mastectomy. Of 408, 195(47.8%) patients had per primum surgery, 126(30.9%), 26(6.4%) and 61(15%) were operated post-1st line chemotherapy, in the recurrent setting and for second breast primary respectively. 260(63.7%) were HER2 positive, 73 ER/PgR + (17.9%) and 75(18.4%) TNBC. Total 256(62.7%) patients received anti-HER2 therapy. The overall complication rate was 12.5%(51/408). Procedural/immediate complications were seen in 3/408(0.7%) patients which included pericardial placement, pleural cavity placement with haemothorax, and intra-operative guidewire migration in 1 patient each. Post-procedural complications were further sub-classified- as short-term complications that included PORT site hematomas in 3/408(0.7%), pocket-site infections in 4/408(0.9%); and long-term complications that included catheter-related bloodstream infections in 13/408(3.2%), catheter related thrombosis in 7/408(1.7%), persistent withdrawal occlusion in 14/408(3.4%), and catheter displacement in 7/408(1.7%).Chemo-PORT placement is an efficient and safe way of administering chemotherapy in breast cancer patients with < 1% serious complication rate. However, timely identification of serious complications can prevent a catastrophe.

Authors

Institutions

Publication Details

Journal
Indian Journal of Surgical Oncology
Published
2025-11-17
DOI
https://doi.org/10.1007/s13193-025-02456-9
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Single-Institution Audit of Chemo-PORT Placements During Breast Surgery with Literature Review for Management of Common Complications

Bhavika Kothari, Shalaka Prakash Joshi, Dileep Ramesh Hoysal, Jessicka Shah et al.
Indian Journal of Surgical Oncology
Breast Cancer Treatment Studies
article

A Single-Institution Audit of Chemo-PORT Placements During Breast Surgery with Literature Review for Management of Common Complications

Bhavika Kothari, Shalaka Prakash Joshi, Dileep Ramesh Hoysal, Jessicka Shah, Suyash Sureshchandra Kulkarni, Mitchelle Engineer, Nitin Shetty, Ankita Nirpharake
article en

Abstract

Abstract Most breast cancer patients need chemotherapy for a duration of 3–12 months. The morbidity of frequent intravenous access, mainly on the contralateral upper limb is troublesome and chemo-PORT placement is helpful. We analysed a prospective database of patients who had concurrent chemo-PORT placement with breast surgery between January-2019 and December-2023 at our centre for their complication rate. Clinico-pathological data was collected from electronic medical records and analysed in SPSS-V25. A total of 408 breast cancer patients underwent chemo-PORT placement. The median age of cohort was 50 years(18–78). Breast conservation surgery was done in 201(49.3%), 207(51.7%) had mastectomy. Of 408, 195(47.8%) patients had per primum surgery, 126(30.9%), 26(6.4%) and 61(15%) were operated post-1st line chemotherapy, in the recurrent setting and for second breast primary respectively. 260(63.7%) were HER2 positive, 73 ER/PgR + (17.9%) and 75(18.4%) TNBC. Total 256(62.7%) patients received anti-HER2 therapy. The overall complication rate was 12.5%(51/408). Procedural/immediate complications were seen in 3/408(0.7%) patients which included pericardial placement, pleural cavity placement with haemothorax, and intra-operative guidewire migration in 1 patient each. Post-procedural complications were further sub-classified- as short-term complications that included PORT site hematomas in 3/408(0.7%), pocket-site infections in 4/408(0.9%); and long-term complications that included catheter-related bloodstream infections in 13/408(3.2%), catheter related thrombosis in 7/408(1.7%), persistent withdrawal occlusion in 14/408(3.4%), and catheter displacement in 7/408(1.7%).Chemo-PORT placement is an efficient and safe way of administering chemotherapy in breast cancer patients with < 1% serious complication rate. However, timely identification of serious complications can prevent a catastrophe.

Indian Journal of Surgical Oncology
Homi Bhabha National Institute (IN)
Openalex Percentile: Top 58%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.